Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.56 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.56 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.53 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | HBB | P68871 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3751854 | 0.91 | PNP (0.59) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL20165850 | 0.84 | PNP (0.64) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL1612645 | 0.84 | PNP (0.56) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL195449 | 0.84 | ADORA3 (0.57) | LMNAHIF1A | |
| SCHEMBL23647921 | 0.83 | PNP (0.62) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL17521212 | 0.83 | PNP (0.62) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL7199411 | 0.83 | PNP (0.62) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL3707304 | 0.83 | PNP (0.62) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL10446997 | 0.82 | PNP (0.64) | PNPLMNATP53HTTPDE4D | |
| SCHEMBL3744956 | 0.82 | PNP (0.60) | PNPLMNATP53HTTPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11266618-B2 | Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG | CITY OF HOPE (US) | 2022-03-08 | — | — | US | claimed |
| US-11179361-B2 | Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG | CITY OF HOPE (US) | 2021-11-23 | — | — | US | claimed |
| US-20180338939-A1 | METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEDG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEDG | CITY OF HOPE | 2018-11-29 | — | — | US | claimed |
| US-20180207116-A1 | METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEDG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEDG | CITY OF HOPE | 2018-07-26 | — | — | US | claimed |
| US-9855233-B2 | Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG | CITY OF HOPE (US) | 2018-01-02 | — | — | US | claimed |
| US-20150290156-A1 | METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEDG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEDG | CITY OF HOPE | 2015-10-15 | — | — | US | claimed |
| US-20120071559-A1 | METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEdG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEdG | RAHBAR SAMUEL (US) | 2012-03-22 | — | — | US | claimed |
| US-20100102218-A1 | METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEdG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEdG | CITY OF HOPE | 2010-04-29 | — | — | US | claimed |
| US-11835499-B2 | Methods of quantifying methylglyoxal-induced nucleic acid adducts | CITY OF HOPE (US) | 2023-12-05 | — | — | US | disclosed |
| US-11835499-B2 | Methods of quantifying methylglyoxal-induced nucleic acid adducts | CITY OF HOPE (US) | 2023-12-05 | — | — | US | disclosed |
| US-11266618-B2 | Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG | CITY OF HOPE (US) | 2022-03-08 | — | — | US | disclosed |
| US-11266618-B2 | Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG | CITY OF HOPE (US) | 2022-03-08 | — | — | US | disclosed |
| US-11179361-B2 | Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG | CITY OF HOPE (US) | 2021-11-23 | — | — | US | disclosed |
| US-11179361-B2 | Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthesis of oligonucleotides containing CEdG | CITY OF HOPE (US) | 2021-11-23 | — | — | US | disclosed |
| US-8277407-B2 | Artificial kidney | RELITECH B.V. (NL) | 2012-10-02 | — | — | US | disclosed |
| US-20120071559-A1 | METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEdG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEdG | RAHBAR SAMUEL (US) | 2012-03-22 | — | — | US | disclosed |
| US-20120071559-A1 | METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEdG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEdG | RAHBAR SAMUEL (US) | 2012-03-22 | — | — | US | disclosed |
| US-20100185134-A1 | Artifical Kidney | RELITECH B.V. (NL) | 2010-07-22 | — | — | US | disclosed |
| US-20100102218-A1 | METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEdG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEdG | CITY OF HOPE | 2010-04-29 | — | — | US | disclosed |
| US-20100102218-A1 | METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEdG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEdG | CITY OF HOPE | 2010-04-29 | — | — | US | disclosed |